tetano
Editor, Senior Moderator
J Family Med Prim Care. 2019 Jun;8(6):2112-2119. doi: 10.4103/jfmpc.jfmpc_265_19.
[h=1]Prevalence of influenza and pneumococcal vaccine uptake in Saudi type 2 diabetic individuals.[/h] Almusalam YA[SUP]1[/SUP], Ghorab MK[SUP]1[/SUP], Alanezi SL[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]Introduction:[/h] Individuals with diabetes are at particularly at high risk for many of the negative health consequences associated with influenza and pneumococcal infections. This study aimed to determine the prevalence of influenza and pneumococcal vaccination among a population of type 2 diabetic patients in Saudi Arabia and to determine the factors associated with vaccine uptake.
[h=4]Methods:[/h] A cross-sectional survey was conducted among patients with type 2 diabetes at Security Forces Hospital, Riyadh in Saudi Arabia. The survey asked basic demographic questions as well as questions about awareness, vaccination status, and beliefs about the influenza and pneumococcal vaccines.
[h=4]Results:[/h] From a total number of 422 responses, 360 participants were ultimately included in the final sample. The overall prevalence of influenza and pneumococcal vaccination in this population were 47.8% and 2.8%, respectively. In general, there was a very low awareness of the pneumococcal vaccine. Older individuals, unmarried individuals, those with less education, and those living with certain chronic conditions were less likely to have gotten the influenza vaccine. Beliefs in the importance of vaccination for people with diabetes, the efficacy of the influenza vaccine, and not being worried about the side effect of the vaccine were strongly associated with having received the vaccine.
[h=4]Conclusions:[/h] Attention should be given to increasing awareness of the pneumococcal vaccine among people living with diabetes. Particular consideration should also be paid to increasing access and awareness to both vaccines among those groups that have the lowest prevalence of vaccination and may be at the highest risk for the negative consequences associated with these infections. Finally, education interventions should be used to increase the understanding of the safety and efficacy of the influenza vaccine.
[h=4]KEYWORDS:[/h] Adult; diabetes mellitus; influenza vaccine; pneumococcal vaccine
PMID: 31334189 PMCID: PMC6618205 DOI: 10.4103/jfmpc.jfmpc_265_19
Free PMC Article
[h=1]Prevalence of influenza and pneumococcal vaccine uptake in Saudi type 2 diabetic individuals.[/h] Almusalam YA[SUP]1[/SUP], Ghorab MK[SUP]1[/SUP], Alanezi SL[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]Introduction:[/h] Individuals with diabetes are at particularly at high risk for many of the negative health consequences associated with influenza and pneumococcal infections. This study aimed to determine the prevalence of influenza and pneumococcal vaccination among a population of type 2 diabetic patients in Saudi Arabia and to determine the factors associated with vaccine uptake.
[h=4]Methods:[/h] A cross-sectional survey was conducted among patients with type 2 diabetes at Security Forces Hospital, Riyadh in Saudi Arabia. The survey asked basic demographic questions as well as questions about awareness, vaccination status, and beliefs about the influenza and pneumococcal vaccines.
[h=4]Results:[/h] From a total number of 422 responses, 360 participants were ultimately included in the final sample. The overall prevalence of influenza and pneumococcal vaccination in this population were 47.8% and 2.8%, respectively. In general, there was a very low awareness of the pneumococcal vaccine. Older individuals, unmarried individuals, those with less education, and those living with certain chronic conditions were less likely to have gotten the influenza vaccine. Beliefs in the importance of vaccination for people with diabetes, the efficacy of the influenza vaccine, and not being worried about the side effect of the vaccine were strongly associated with having received the vaccine.
[h=4]Conclusions:[/h] Attention should be given to increasing awareness of the pneumococcal vaccine among people living with diabetes. Particular consideration should also be paid to increasing access and awareness to both vaccines among those groups that have the lowest prevalence of vaccination and may be at the highest risk for the negative consequences associated with these infections. Finally, education interventions should be used to increase the understanding of the safety and efficacy of the influenza vaccine.
[h=4]KEYWORDS:[/h] Adult; diabetes mellitus; influenza vaccine; pneumococcal vaccine
PMID: 31334189 PMCID: PMC6618205 DOI: 10.4103/jfmpc.jfmpc_265_19
Free PMC Article